Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memoriam: Michael Albert Lemp.

Cornea·2025
Same author

Validation of a Modified National Eye Institute Grading Scale for Corneal Fluorescein Staining.

Clinical ophthalmology (Auckland, N.Z.)·2023
Same author

Perspective on Systematic Medical Literature Reviews and Meta-Analyses.

American journal of ophthalmology·2019
Same author

Human Meibum Cholesteryl and Wax Ester Variability With Age, Sex, and Meibomian Gland Dysfunction.

Investigative ophthalmology & visual science·2019
Same author

TFOS DEWS II Introduction.

The ocular surface·2017
Same author

TFOS DEWS II Clinical Trial Design Report.

The ocular surface·2017
Same journal

A post-HSCT ocular surface "Window of Opportunity for Pre-emptive ocular treatment" (WinOP) shows early inflammatory activation and an oGVHD-like molecular subset.

The ocular surface·2026
Same journal

Pipeline: Eugene Garfield, Ph.D. and Bibliometrics.

The ocular surface·2026
Same journal

The ocular surface consequences of lacrimal gland loss are life-stage dependent.

The ocular surface·2026
Same journal

Evaluating synthetic anterior segment images for transferable eye disease recognition.

The ocular surface·2026
Same journal

Beyond diagnosis: AI-based surgical risk assessment in Acanthamoeba keratitis with real-world validation.

The ocular surface·2026
Same journal

Impact of the loss of tenascin X on tissue architecture and wound healing of the murine corneal stroma.

The ocular surface·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Solutes, surgery and the ocular surface

Gary N Foulks

    The Ocular Surface
    |May 7, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
    03:40

    Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

    Published on: April 25, 2025

    Related Experiment Videos

    Last Updated: Jun 2, 2026

    Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
    04:59

    Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

    Published on: July 7, 2023

    Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
    03:40

    Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

    Published on: April 25, 2025